Lucentis and Hemianopia - a phase IV clinical study of FDA data

Summary:

Hemianopia is reported only by a few people who take Lucentis.

The study analyzes which people take Lucentis and have Hemianopia. It is created by eHealthMe based on reports of 25,577 people who have side effects while taking Lucentis from the FDA, and is updated regularly.

What is Lucentis?

Lucentis has active ingredients of ranibizumab. It is often used in macular degeneration. eHealthMe is studying from 25,647 Lucentis users. Check the latest studies of Lucentis.

What is Hemianopia?

Hemianopia (blindness or reduction in vision in one half of the visual field due to damage of the optic pathways in the brain) is found to be associated with 254 drugs and 398 conditions by eHealthMe. Check the latest studies of Hemianopia.

On Jan, 07, 2026

25,577 people reported to have side effects when taking Lucentis.
Among them, 4 people (0.02%) have Hemianopia.

Among these 4 people:

How long have people been on Lucentis when they have Hemianopia? *

What is the gender of people who have Hemianopia when taking Lucentis? *

female: 50 %
male: 50 %

What is the age of people who have Hemianopia when taking Lucentis? *

What are other drugs people take besides Lucentis? *

Nexium: 1 person, 25.00%
Lumigan: 1 person, 25.00%
Cosopt: 1 person, 25.00%

What are other side effects people have besides Hemianopia? *

Speech Impairment (Adult) (inability to speak (adult)): 2 people, 50.00%
Visual Acuity Reduced (reduced clearness of vision): 1 person, 25.00%
Vision Blurred: 1 person, 25.00%
Transient Ischaemic Attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow)): 1 person, 25.00%
Thrombocytopenia (decrease of platelets in blood): 1 person, 25.00%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 25.00%
High Blood Pressure: 1 person, 25.00%
Cerebral Infarction (less blood supply to brain resulting tissue damage): 1 person, 25.00%
Cerebral Haemorrhage (bleeding within the brain): 1 person, 25.00%
Brain Oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain): 1 person, 25.00%

What are the existing conditions these people have? *

Diabetic Retinal Oedema (excessive build-up of fluid in the retina due to diabetes): 1 person, 25.00%
Age-Related Macular Degeneration: 1 person, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take Lucentis and have Hemianopia?

- Check whether Hemianopia is associated with a drug or a condition (FREE)
- Predict drug outcomes for up to one year with AI (FREE)
- Get an AI agent to monitor your drugs continuously (FREE)

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lucentis:

Lucentis (25,647 reports)

Hemianopia treatments and more:

Hemianopia (1,234 reports)

Browse all side effects of Lucentis:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hemianopia:

Hemianopia (254 drugs)

Browse all the conditions that are associated with Hemianopia:

Hemianopia (398 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ranibizumab (the active ingredients of Lucentis) and Lucentis (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.